P45.12 Renal Function Change During Alectinib in ALK Rearranged Non-Small Cell Lung Cancer: A Retrospective Multicentre Analysis

2021 ◽  
Vol 16 (10) ◽  
pp. S1090
Author(s):  
D. Pignataro ◽  
C. Paratore ◽  
M. Di Maio ◽  
M. Tucci ◽  
S. Novello
Keyword(s):  
Lung Cancer ◽  
Renal Function ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Small Cell Lung ◽  
Function Change

Better survival in impaired renal function patients with metastatic non-small cell lung cancer treated by cisplatin-pemetrexed

2020 ◽  
Vol 76 (11) ◽  
pp. 1573-1580
Author(s):  
Louis Magali ◽  
Foucher Pascal ◽  
Aho Serge ◽  
Boulin Mathieu ◽  
Zouak Ayoube ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Renal Function ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Impaired Renal Function ◽  
Small Cell ◽  
Small Cell Lung

Effects of Gemcitabine on renal function in patients with non-small cell lung cancer

1998 ◽  
Vol 34 (1) ◽  
pp. 199-202 ◽  
Author(s):  
J.A Gietema ◽  
H.J.M Groen ◽  
S Meijer ◽  
E.F Smit
Keyword(s):  
Lung Cancer ◽  
Renal Function ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Small Cell Lung

scholarly journals Acute Interstitial Nephritis in a Patient with Non-Small Cell Lung Cancer under Immunotherapy with Nivolumab

2019 ◽  
Vol 2019 ◽  
pp. 1-5
Author(s):  
Panagiotis I. Georgianos ◽  
Vasilios Vaios ◽  
Eleni Leontaridou ◽  
Georgia Karayannopoulou ◽  
Triantafyllia Koletsa ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Renal Function ◽  
Small Cell Lung Cancer ◽  
Interstitial Nephritis ◽  
Cell Lung Cancer ◽  
Acute Interstitial Nephritis ◽  
Small Cell ◽  
Close Monitoring ◽  
Partial Recovery ◽  
Small Cell Lung

Immune-checkpoint-inhibitors (ICPIs) represent a novel class of immunotherapy against several malignancies. These agents are associated with several “immune-mediated” adverse effects, but the reported renal toxicity of ICPIs is less well defined. We present the case of a 60-year-old man with a history of non-small cell lung cancer, who developed acute kidney injury (AKI) approximately 3.5 months after initiation of immunotherapy with nivolumab. Urinalysis revealed sterile pyuria, without microscopic hematuria or proteinuria. Immunological examination was negative. A renal biopsy showed severe interstitial inflammatory infiltration of T-cells, monocytes, and eosinophils without interstitial granulomas and normal appearance of glomeruli, indicating acute interstitial nephritis (AIN) as the cause of AKI. After a short-term course of corticosteroids and permanent nivolumab discontinuation, partial recovery of renal function was noted. AIN is a rare adverse effect of ICPIs that mandates the close monitoring of renal function in patients under immunotherapy with these agents.

Difference in decline in renal function due to cisplatin after a short or long hydration scheme in non–small‐cell lung cancer: A retrospective cohort study (HYCIS‐XL)

2020 ◽  
Vol 45 (5) ◽  
pp. 1153-1158 ◽  
Author(s):  
Kelly L. Niggebrugge‐Mentink ◽  
Marieke M. Beex‐Oosterhuis ◽  
Peter G. J. Horst ◽  
Matthijs E. C. Poll ◽  
Hetty G. Dieleman ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Renal Function ◽  
Cohort Study ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Retrospective Cohort Study ◽  
Retrospective Cohort ◽  
Small Cell ◽  
Small Cell Lung

Effects of Renal Function on Crizotinib Pharmacokinetics: Dose Recommendations for Patients with ALK-Positive Non-Small Cell Lung Cancer

2016 ◽  
Vol 37 (4) ◽  
pp. 363-373 ◽  
Author(s):  
Weiwei Tan ◽  
Shinji Yamazaki ◽  
Theodore R. Johnson ◽  
Rong Wang ◽  
Melissa T. O’Gorman ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Renal Function ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Small Cell Lung ◽  
Alk Positive ◽  
Dose Recommendations
Sign in / Sign up

Export Citation Format

Share Document